Orodispersible Tablets Market Growth Accelerated by Increased Patient Compliance


 Orodispersible tablets are solid tablets intended to be placed in the mouth where they disperse rapidly, usually within a matter of seconds, before being swallowed, without the need for water or chewing. They are extremely convenient for patients who have difficulty in swallowing conventional tablets and provide faster action than conventional tablets. The increasing number of pediatric and geriatric patients are driving the demand for these tablets due to ease of administration without water. The global Orodispersible Tablets Market is estimated to be valued at US$ 4.9 Bn in 2023 and is expected to exhibit a CAGR of 8.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:

The increased demand for faster acting drug delivery systems and higher patient compliance are expected to drive the growth of the global orodispersible tablets market over the forecast period. Rising prevalence of various diseases accompanied with difficulty in swallowing conventional tablets has led to surge in demand for innovative drug delivery systems. Moreover, technological advancements in tablet formulations to incorporate active ingredients that can dissolve rapidly have boosted the market growth. Manufacturers are focusing on development of improved formulations for both pediatric and geriatric population. Strong pipeline of drugs in the form of orodispersible tablets is also expected to support market growth during the forecast period.

Segment Analysis
The global orodispersible tablets market is dominated by the anti-psychotics segment, which accounts for over 30% share. This is because anti-psychotics are widely used to treat several mental health conditions like schizophrenia and bipolar disorder. These conditions have high prevalence globally and require good patient compliance and convenience which orodispersible tablets provide by dissolving rapidly in the oral cavity without water.

Key Takeaways
The global orodispersible tablets market is expected to witness high growth driven by increasing preference for convenience dosage forms and rising mental health disorders globally.

Regional analysis: North America currently dominates the market due to high healthcare expenditure and early adoption of novel drug delivery technologies. However, Asia Pacific is expected to witness fastest growth during the forecast period due to rising incomes, healthcare expansions and growing patient demand in developing countries like India and China.

Key players: Key players operating in the orodispersible tablets market are Alnylam Pharmaceuticals, IntelGenx, Pfizer, GSK and others. Alnylam Pharmaceuticals leads with its diverse product portfolio of orally delivered therapies for genetic medicines. IntelGenx focuses on formulation technologies for improved solubility and oral delivery of drugs. Pfizer and GSK have a strong presence with their antipsychotic and antiepileptic drugs available as orodispersible tablets. 

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more